OpenAI Set to Secure Multi-Billion Dollar Investment from SoftBank

OpenAI is poised to significantly amplify its Artificial Intelligence pursuits with substantial backing from SoftBank.

OpenAI, the renowned Artificial Intelligence startup, is on the brink of securing a significant new investment round led by SoftBank. This funding, reportedly in the billions, is expected to almost double the valuation of the company. It marks a pivotal moment for OpenAI as it accelerates its development and deployment of advanced AI technologies.

With this influx of capital, OpenAI aims to bolster its capabilities in AI research and the broader implementation of its technologies across various sectors. The confidence shown by SoftBank, a prominent investor known for its large-scale tech investments, underscores the growing importance and potential of Artificial Intelligence. This financial backing is anticipated to further solidify OpenAI´s position as a leader in the AI field.

The investment will likely enable OpenAI to expand its reach and influence, providing it with the resources to innovate and tackle complex AI challenges. As the company gears up for this new chapter, it continues to emphasize its commitment to ensuring AI technologies benefit humanity as a whole. This development also highlights the increasing intersection between leading tech firms and major investors seeking to shape the future of AI.

73

Impact Score

Crescent library brings privacy to digital identity systems

Crescent is a cryptographic library that adds unlinkability to common digital identity formats, preventing tracking across credential uses while preserving selective disclosure. It supports JSON Web Tokens and mobile driver’s licenses without requiring issuers to change their systems.

Artificial Intelligence-powered remote drug testing removes barriers to recovery

Q2i and King’s College London are collaborating to evaluate an Artificial Intelligence-powered at-home drug testing system aimed at people recovering from opioid use disorder. The solution delivers digitally observed, clinically reliable results and pairs testing with contingency management and telehealth to reduce logistical barriers to care.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.